SCHEMBL4637372

SCHEMBL4637372

C#CC[C@@]12C[C@H](O[Si](C)(C)C(C)(C)C)CN1C(=O)C(c1cc(Cl)cc(Cl)c1)=C2O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4638957 1.00
SCHEMBL4638944 0.82 ITGAL (0.33)
SCHEMBL4913351 0.82 ITGAL (0.33)
SCHEMBL4801893 0.82 TRPV4 (0.33)
SCHEMBL4797574 0.74 TRPV4 (0.31)
SCHEMBL4915815 0.74 ITGAL (0.37)
SCHEMBL4912803 0.74 ITGAL (0.37)
SCHEMBL4638100 0.70 MEN1 (0.30)
SCHEMBL4638268 0.70 MEN1 (0.30)
SCHEMBL4637829 0.70 ITGAL (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080262070-A1 Pharmaceutically Active Tetrahydro-Pyrrolizinone Compounds BAUMANN KARL 2008-10-23 US disclosed
EP-1937685-A1 TETRAHYDRO-PYRROLIZINONE COMPOUNDS AS LFA-I MEDIATORS Novartis AG (CH) 2008-07-02 EP disclosed
WO-2007039286-A1 TETRAHYDRO-PYRROLIZINONE COMPOUNDS AS LFA-I MEDIATORS NOVARTIS AG (CH) 2007-04-12 WO disclosed